Bio-Rad Laboratories Gross Margin 2010-2023 | BIO.B
Current and historical gross margin for Bio-Rad Laboratories (BIO.B) over the last 10 years. The current gross profit margin for Bio-Rad Laboratories as of March 31, 2023 is %.
| Bio-Rad Laboratories Gross Margin Historical Data |
| Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
| 2023-03-31 |
$2.78B |
$1.53B |
54.95% |
| 2022-12-31 |
$2.80B |
$1.57B |
55.96% |
| 2022-09-30 |
$2.81B |
$1.57B |
56.01% |
| 2022-06-30 |
$2.87B |
$1.63B |
56.91% |
| 2022-03-31 |
$2.90B |
$1.64B |
56.63% |
| 2021-12-31 |
$2.92B |
$1.64B |
56.04% |
| 2021-09-30 |
$2.98B |
$1.70B |
57.05% |
| 2021-06-30 |
$2.88B |
$1.63B |
56.60% |
| 2021-03-31 |
$2.70B |
$1.52B |
56.31% |
| 2020-12-31 |
$2.55B |
$1.44B |
56.44% |
| 2020-09-30 |
$2.38B |
$1.31B |
54.92% |
| 2020-06-30 |
$2.29B |
$1.25B |
54.36% |
| 2020-03-31 |
$2.33B |
$1.26B |
54.16% |
| 2019-12-31 |
$2.31B |
$1.26B |
54.37% |
| 2019-09-30 |
$2.31B |
$1.26B |
54.66% |
| 2019-06-30 |
$2.29B |
$1.24B |
54.17% |
| 2019-03-31 |
$2.29B |
$1.23B |
53.84% |
| 2018-12-31 |
$2.29B |
$1.22B |
53.45% |
| 2018-09-30 |
$2.29B |
$1.24B |
53.88% |
| 2018-06-30 |
$2.28B |
$1.25B |
54.66% |
| 2018-03-31 |
$2.21B |
$1.22B |
55.11% |
| 2017-12-31 |
$2.16B |
$1.19B |
54.95% |
| 2017-09-30 |
$2.11B |
$1.16B |
54.83% |
| 2017-06-30 |
$2.09B |
$1.14B |
54.53% |
| 2017-03-31 |
$2.10B |
$1.14B |
54.55% |
| 2016-12-31 |
$2.07B |
$1.14B |
55.03% |
| 2016-09-30 |
$2.07B |
$1.13B |
54.74% |
| 2016-06-30 |
$2.03B |
$1.12B |
55.00% |
| 2016-03-31 |
$2.02B |
$1.12B |
55.30% |
| 2015-12-31 |
$2.02B |
$1.12B |
55.54% |
| 2015-09-30 |
$2.05B |
$1.13B |
55.20% |
| 2015-06-30 |
$2.11B |
$1.16B |
54.84% |
| 2015-03-31 |
$2.14B |
$1.17B |
54.84% |
| 2014-12-31 |
$2.18B |
$1.18B |
54.16% |
| 2014-09-30 |
$2.18B |
$1.18B |
54.31% |
| 2014-06-30 |
$2.15B |
$1.18B |
54.74% |
| 2014-03-31 |
$2.14B |
$1.18B |
55.18% |
| 2013-12-31 |
$2.13B |
$1.18B |
55.23% |
| 2013-09-30 |
$2.10B |
$1.17B |
55.61% |
| 2013-06-30 |
$2.10B |
$1.16B |
55.29% |
| 2013-03-31 |
$2.08B |
$1.15B |
55.11% |
| 2012-12-31 |
$2.07B |
$1.16B |
55.87% |
| 2012-09-30 |
$2.05B |
$1.15B |
56.38% |
| 2012-06-30 |
$2.06B |
$1.18B |
56.96% |
| 2012-03-31 |
$2.08B |
$1.18B |
56.87% |
| 2011-12-31 |
$2.07B |
$1.18B |
56.85% |
| 2011-09-30 |
$2.06B |
$1.17B |
56.71% |
| 2011-06-30 |
$2.01B |
$1.14B |
56.48% |
| 2011-03-31 |
$1.96B |
$1.11B |
56.76% |
| 2010-12-31 |
$1.93B |
$1.09B |
56.59% |
| 2010-09-30 |
$1.89B |
$1.06B |
56.06% |
| 2010-06-30 |
$1.88B |
$1.05B |
56.12% |
| 2010-03-31 |
$1.84B |
$1.03B |
55.96% |
| 2009-12-31 |
$1.78B |
$1.00B |
56.05% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$10.988B |
$2.802B |
|
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
|
